NCT06132789View on ClinicalTrials.gov

A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried in a Population Aged 10-60 Years

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 27, 2023

Primary Completion Date

August 16, 2024

Study Completion Date

August 16, 2024

Conditions
Rabies
Interventions
BIOLOGICAL

Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried

This vaccine（1.0ml） is produced by Ab\&b Biotechnology Co., Ltd.JS. Subjects will receive the Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried vaccinated by intramuscular injection.

Trial Locations (1)

Unknown

Gucheng Center for Disease Control and Prevention, Xiangyang

All Listed Sponsors
collaborator

Hubei Provincial Center for Disease Control and Prevention

OTHER

lead

Ab&B Bio-tech Co., Ltd.JS

OTHER

NCT06132789 - A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried in a Population Aged 10-60 Years | Biotech Hunter | Biotech Hunter